Mona Alfaraj: Therapeutic Apheresis Case Series in Sickle Cell Disease with Fat Embolism Syndrome
Mona Alfaraj, Consultant Hematopathologist and Transfusionist, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Hemoglobin:
“Happy to share that one of our works on therapeutic apheresis has been published. Grateful for the collaboration and the opportunity to contribute in a scientific work that supports better patient care. Proud of the team and the journey behind this work.
For those with trasfusion and apheresis interest, it is worth to emphasize that although plasma is the standard replacement fluid in TPE for FES, a 50:50 replacement protocol using FFP and 5% human albumin was used in both reported cases. This approach aligns with ASFA guidelines , which recommend limiting full FFP replacement to conditions with clear coagulopathy or high bleeding risk.
In sickle cell disease, this mixed replacement strategy aims to reduce donor plasma exposure while ensuring that the FFP provided is sufficient to address any preexisting or exchange-induced coagulopathy.
A similar protocol has been used in other studies involving critically ill patients with sickle cell disease and multi organ failure.
This case series is a step of greater project of optimum utilization of plasma in therapeutic plasma exchange .”
Title: Therapeutic Plasma Exchange as a Rescue Therapy in Sickle Cell Disease-Associated Fat Embolism Syndrome: Case Series and Literature Review
Authors: Abdulmohsen K. Aljishia, Fatimah A. Alrabia, Abdullah M. Al Abbas, Mona M. Alfaraji, Fadhel A. Alomard, Salah Abohelaikac
Read the Full Article on Hemoglobin
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Jun 28, 2026, 10:34Heghine Khachatryan: Menarche as the First ‘Bleeding Challenge’
-
Jun 28, 2026, 10:13Mohammed Alharbi: Assessing Warfarin Management and Anticoagulation Quality in Older Populations
-
Jun 28, 2026, 10:03Rick Kapur: Current Understanding of FNAIT Regarding Diagnostics, Pathophysiology and Management
-
Jun 28, 2026, 09:55Utkarsh Pandey: Japan Approves Wayrilz for ITP Patients
-
Jun 28, 2026, 09:41Sung-mok Jung: How Environmental Drivers Influence SFTS Occurrence
-
Jun 28, 2026, 05:17Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
-
Jun 28, 2026, 05:08Kathrine Kaspersen: The Power of Voluntary Plasma Donation
-
Jun 28, 2026, 04:55Sana Helani: Challenging Common Assumptions in Anemia Management
-
Jun 28, 2026, 04:55Samwel Mikaye: The Collapse of Coagulation Control in Disseminated Intravascular Coagulation